Standard DKA Protocol for a 60-kg Adult
For moderate-to-severe DKA in a 60-kg adult, initiate continuous intravenous regular insulin at 0.1 units/kg/hr (6 units/hr) after an initial bolus of 0.15 units/kg (9 units), combined with aggressive fluid resuscitation using isotonic crystalloids, while carefully monitoring and replacing potassium. 1
Initial Assessment & Diagnosis
Confirm DKA with:
- Blood glucose ≥250 mg/dL
- Venous pH <7.3
- Bicarbonate <15 mEq/L
- Moderate ketonuria or ketonemia 1
Obtain STAT labs: glucose, venous blood gases, complete metabolic panel (electrolytes, BUN, creatinine), calcium, phosphorus, and urinalysis 1
Critical caveat: Measure β-hydroxybutyrate (β-OHB) in blood rather than urine ketones. The nitroprusside method only detects acetoacetic acid and acetone, not β-OHB (the predominant ketone in DKA). During treatment, β-OHB converts to acetoacetic acid, falsely suggesting worsening ketosis. 1
Fluid Resuscitation (First Priority)
Start with isotonic crystalloid (0.9% saline or balanced crystalloid like Plasmalyte-148) immediately. Fluid replacement is the most critical initial intervention. 2, 1
- Initial rate: Aggressive hydration to correct the substantial fluid deficit (typically several liters)
- Correct serum sodium for hyperglycemia: add 1.6 mEq/L to measured sodium for every 100 mg/dL glucose elevation 1
Recent evidence suggests balanced crystalloids (Plasmalyte-148) may accelerate metabolic acidosis resolution compared to normal saline (69% vs 36% at 24 hours, p=0.002) 3, though both are acceptable.
Insulin Therapy
For Moderate-to-Severe DKA:
Exclude hypokalemia first (K+ must be ≥3.3 mEq/L before starting insulin) 1
Initial dosing for your 60-kg patient:
- IV bolus: 0.15 units/kg = 9 units regular insulin
- Continuous infusion: 0.1 units/kg/hr = 6 units/hr regular insulin 1
Expected glucose decline: 50-75 mg/dL per hour 1
If glucose doesn't fall by 50 mg/dL in the first hour: Check hydration status; if adequate, double the insulin infusion rate every hour until achieving steady decline of 50-75 mg/dL/hr 1
Critical Insulin Adjustment:
When glucose drops below 250 mg/dL: Add dextrose-containing IV fluids (two-bag method preferred) 4, 5
When glucose drops below 14 mmol/L (252 mg/dL): Consider de-escalating insulin infusion from 0.1 to 0.05 units/kg/hr (from 6 to 3 units/hr for your 60-kg patient) to reduce hypoglycemia risk 4
This recommendation addresses the high prevalence of hypoglycemia noted in recent guideline updates. The two-bag method (one bag with saline/balanced crystalloid, one with dextrose) allows continued insulin infusion while preventing hypoglycemia, and has shown shorter time to DKA resolution, reduced hypoglycemia (3-10% vs 30%), and shorter hospital stays compared to traditional one-bag methods 5, 3.
For Mild DKA Only:
Subcutaneous or intramuscular regular insulin is acceptable:
- Priming dose: 0.4-0.6 units/kg (24-36 units for 60-kg patient), half IV bolus and half SC/IM
- Maintenance: 0.1 unit/kg SC/IM every hour 1
Potassium Replacement (Critical)
Hypokalaemia occurs in ~50% of DKA cases during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality. 2
- If K+ <3.3 mEq/L: Hold insulin and give potassium replacement first
- If K+ 3.3-5.0 mEq/L: Add 20-30 mEq potassium to each liter of IV fluid
- If K+ >5.0 mEq/L: Hold potassium replacement but monitor closely 1
Use combination: 2/3 KCl (or K-acetate) and 1/3 KPO4 1
Monitoring
Every 2-4 hours: Glucose, electrolytes, BUN, creatinine, venous pH, anion gap 1
Venous blood gases are sufficient—arterial blood gases are generally unnecessary. Venous pH runs ~0.03 units lower than arterial. 1
Continuous monitoring: Cardiac monitoring (for potassium-related arrhythmias), vital signs, mental status
Bicarbonate Therapy
Do NOT give bicarbonate if pH ≥7.0 1
Consider bicarbonate only if pH <6.9: Evidence is weak, but may be beneficial in severe acidosis. If used, give cautiously to avoid cerebral edema risk. 1
Phosphate Replacement
Routine phosphate replacement is NOT recommended—studies show no clinical outcome benefit 1
Consider replacement only if:
- Serum phosphate <1.0 mg/dL (0.32 mmol/L)
- Cardiac dysfunction present
- Anemia present
- Respiratory depression present 1
Resolution Criteria
DKA is resolved when ALL of the following are met:
- Glucose <200 mg/dL
- Serum bicarbonate ≥18 mEq/L
- Venous pH ≥7.3 1
Important: Ketonemia takes longer to clear than hyperglycemia. Don't stop treatment based on glucose alone. 1
Transition to Subcutaneous Insulin
Once DKA is resolved and patient can eat:
Calculate total daily subcutaneous insulin dose from the average insulin infusion rate over the preceding 12 hours. For example, if averaging 1.5 units/hr × 24 hours = 36 units/day 2
Start basal-bolus regimen with combination of long-acting (basal) and rapid/short-acting (prandial) insulin 1
Continue IV insulin for 1-2 hours AFTER starting subcutaneous insulin to ensure adequate overlap and prevent rebound hyperglycemia 1
Critical pitfall: Abrupt discontinuation of IV insulin without adequate subcutaneous overlap leads to poor glycemic control and potential DKA recurrence. 1
Special Considerations
SGLT2 inhibitor use: Increases risk of euglycemic DKA (normal or near-normal glucose with ketoacidosis). Maintain high index of suspicion. 4
End-stage renal disease/dialysis: Standard protocols require modification; consult nephrology early. 4
Cerebral edema risk: More common in pediatrics but can occur in adults. Avoid overly rapid correction of glucose and osmolality. Use isotonic fluids initially. 1